Anaheim, CA, May 02, 2018 (GLOBE NEWSWIRE) -- LiveWire Ergogenics, Inc. (OTC: LVVV), a company focused on special purpose real estate acquisitions, the licensing and management of fully compliant turnkey production facilities for cannabis-based products announced today that it has signed a Letter of Intent with Mojave Jane, LLC, a licensed and legal manufacturer of premium cannabis extracts and concentrates for the California market.
According to the LOI, LiveWire Ergogenics, through its wholly owned subsidiary GHC Ventures, has been granted rights as the Master Distributor for all Mojave Jane products. LiveWire will also acquire a minority equity interest in Mojave Jane in an all-stock transaction and be granted a seat on the company’s Advisory Board. Livewire has agreed to a 12-month option to acquire 100% of Mojave Jane, LLC.
“This Master Distributorship for Mojave Jane’s entire product line will allow LiveWire to generate significant top line revenue for the companies,” states LiveWire CEO Bill Hodson. “Acting as the Master Distributor will allow the two corporate teams to get well acquainted with each other and provide both parties with the opportunity to conduct thorough due diligence to enter into a final agreement.”
Gary Latham, one of the Managing Members of Mojave Jane adds, "LiveWire Ergogenics has assembled an impressive team of experts and is executing on a solid strategy and plan. We believe that LiveWire is on the path to be a market leader and is a great platform for market penetration and sales in the legal cannabis market. We are very excited to partner with LiveWire and drive value to all of our respective businesses.”
About Mojave Jane
Mojave Jane, LLC is a licensed and legal manufacturer of premium cannabis extracts and concentrates for the California market. Based in Coachella, CA, Mojave Jane utilizes state of the art CO2 extraction technologies, organic and pesticide free materials and advanced distillation techniques to create an array of products for both recreational and medical cannabis users.
About LiveWire Ergogenics, Inc.
LiveWire Ergogenics, Inc. (LVVV) specializes in identifying and monetizing current and future trends in the health and wellness industry. The Company is focused on acquiring and licensing specialized turnkey cannabis real estate locations and establishing research partnerships to explore the application of cannabinoid-based products to target specific ailments or conditions with large “sufferer” populations for human and veterinarian applications. This includes the cloning of cannabis strains to produce positive medicinal results, dosing verification of zero pesticide products for quality brands via its “7X Pure” Cannabis Dosing and Verification System, and development and licensing of high-quality cannabinoid-based products and services. The team at LiveWire Ergogenics has a passion for research and is committed to generating and implementing innovative ideas and producing high-quality and fully compliant products that satisfy an increasing demand in this fast-growing industry.
For more information about LiveWire Ergogenics, visit http://www.livewireergogenics.com. For non-material updates, follow LiveWire Ergogenics on Twitter @livewireLVVV. Download the Stockwatchindex Research Report at http://www.swiresearch.com/report-index
Forward-Looking Statements
Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements. Forward-looking statements may include, without limitation, financial projections, statements regarding the plans and objectives of management for future operations, the development, regulatory approvals and commercialization of the Company’s products, or any of the Company’s other proposed products, systems or services. Such forward-looking statements are not meant to predict or guarantee actual results and performance, events or circumstances and actual events may differ considerably. Factors that may cause actual results to differ materially from any projections may include, without limitation, the Company’s inability to obtain additional financing, delays in the development of its products, the impact of significant new or changing government regulation in the cannabis industry, existing or increased competition, results of arbitration and litigation, stock volatility and illiquidity, and the Company’s failure to implement the Company’s business plans or strategies. The Company assumes no obligation to update any forward-looking statements to reflect any event or circumstance that may arise after the date of this release.